Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin K intake, VKORC1 genotype, and warfarin response study
2008-006451-52Phase 4Terminated
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of warfarin in thromboembolism, Phlebothrombosis, arterial thrombosis and 1 more, sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoints: Weekly dietary vitamin K intake, VKORC1 genotype and 2 more. Started Feb 2009; status: terminated.
02
Drugs
warfarin
03
Conditions
thromboembolismPhlebothrombosisarterial thrombosisembolism
Beyond the preview
Go deeper on 2008-006451-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006451-52.